Abstract
The Problem of Comorbidity
Both the Diagnostic and Statistic Manual of Mental Disorders (DSM) and International Statistical Classification of Diseases and Related Health Problems (ICD) categorise anxiety and depression as different types of mental disorder. The ICD-10 categorises anxiety disorders as part of the spectrum of neurotic, stress-related and somatoform disorders, and depression under mood/affective disorders. 1 Although formerly under different sections in earlier versions, the recent DSM-5 places these in a general mental disorder category, with categories specific to depressive disorders and anxiety disorders, and further subdivided into different variations.
2 Despite terminological differences, the two associate anxiety disorders with anxious and fearful psychological and physiological symptoms, and depressive disorders with low mood, motivation, and negative affect. An estimated quarter of the population of the Untied States of America are estimated to have been afflicted by an anxiety disorder within (dPFC).
14 In healthy pathologically low anxiety individuals, threatening stimuli increase activity in the PFC, whilst high anxiety participants are less responsive. 15 Despite this lower activity, individuals with generalised anxiety disorder posses higher levels of metabolism in the dPFC. 16, 17 Depression too is associated with reduced activity in the dPFC. 18 Furthermore extensive damage to multiple areas in the PFC is positively associated with depressive symptoms, with damage to the dPFC regions rendering the most severe symptoms. 19 The amygdala modulates fear responses. 20 Increased amygdala activity has been linked to decreased dPFC activity in both healthy and depressed individuals. 21, 22, 23 However amygdala activity varies amongst depressed individuals, with some possessing above average volume and activity, and others reduced volume and activity compared to healthy individuals, which Sacher et al. propose may signify the respective differences between individuals suffering from first episodes of major depression and those with recurring episodes. 24 The hippocampus is known to be the core area of the brain dedicated to memory, having an impact on all memory related cognition. 25 Anxiety in general is associated with increased activity in the anterior hippocampus, and state anxiety with the addition of increased connectivity with the PFC. 26 State anxiety is the conscious cognitive perception of threats, reflected in PFC activity, whilst the more automatic trait anxiety response is associated with connectivity to the more sensory and unconscious posterior cortical regions of the brain. 27 Depression however is associated with atrophy throughout hippocampus.
The anterior cingulate cortex (ACC) is associated with memory recall. 30 In adolescents, rumination was associated with an increased likelihood of developing depression, having had a past depressive episode, and the duration and severity of depressive episodes. 31, 32 Depression often shows greater subgenual ACC activity and metabolism, with correlation to ruminative tendencies. 33, 34, 35 Furthermore the degree of ACC responsiveness to social stresses is positively correlated with the onset of depressive symptoms. 36 Diminished ACC activity in depression however is negatively correlated with recovery rates. 37 Considering anxiety has an earlier age of onset than depression and predicts depression later in life, 38, 39, 40 would appear to imply that responsiveness to perceived threats or stresses and the chronic re-experience of these in the form of rumination may play a role in the onset of depression and its ongoing severity.
Thus the behavioural and neurological states are polarised in the disorders of anxiety and depression. However considering there are studies that find anxiety precedes depression and is even predictive of depressive episodes in individuals, 41, 42, 43, 44 one may propose some relation exists from one to the other. This very hypothesis has been posited indirectly by the occupational burnout hypothesis. The concept of burnout outlines how individuals suffering from anxieties and strains in the form of occupational stress are more likely to be exhausted and develop depressive symptoms. 45, 46 Factors such as neuroticism, gender, financial strain, job satisfaction, domestic issues, chronic medical illness, and depressive symptoms are identified as specific stressors related to the severity of burnout over time. 47 Bianchi, Schonfeld & Laurent found that 90% of their participants identified as burned out using a psychometric burnout scale met the DSM-IV criterion for depression, and that increased ratings of burnout correlated with increased severity of depressive symptoms. 48 Thus it is implied according to the burnout theory, that excessive anxiety and stress over time has an influence on the onset depressive symptoms.
Biochemical Evidence of an Anxious Pathology
The evidence that can tie the behavioural and neuroimaged observations, is the role of excitatory neurotransmitters. It is worth noting that the word anxiety itself and its symptoms imply anticipatory psychological and physiological arousal. Vital to this process is glutamate, an excitatory neurotransmitter that stimulates the activity of the sympathetic nervous system and accounts for up to 50-60% of neurotransmission in the brain. 49 Although essential for basic functioning and survival, the neurotoxicity of excessive glutamate upon neurons is noteworthy. 50, 51, 52, 53 In rats developmental stresses facilitated and increased glutamate release in the amygdala. 54 Considering the amygdala's connectivity to various regions of the brain, 55 such sensitisation may trigger a cascading fear/anxiety response throughout the brain. Furthermore chronic stress also reduces functioning and damages neurons in the hippocampus and PFC, the precise areas found damaged in depressive disorders. 56, 57, 58 Glutamate antagonists are effective as antidepressant medications, and many present antidepressants and anxiety treating benzodiazepines interfere with and reduce glutamate release and uptake. 59, 60, 61 It is also noteworthy that many popular informal drugs such as alcohol, cannabis, and non-steroidal anti-inflammatory drugs (e.g. acetaminophen, aspirin, ibuprofen) all either suppress release or suppress uptake of glutamate in the brain, giving insight into the prevalence of drug use in anxiety and mood disorders. 66, 67 Thus the neural damage of depression could be caused by an excess of stress related neurochemicals, which although essential for activity and functioning, in excess result in neurological damage. These effects are reflected in visible energy levels, cognitive abilities, and compensatory (e.g. self-medicating) behaviours common to anxiety and depression.
Biomarkers in the blood have been indicated for both anxiety and depression in the form of cholesterol, with heightened levels of high-density lipoprotein (HDL) associated with heightened levels of anxiety and depression, and higher levels of low-density lipoprotein (LDL) with lower levels of anxiety and depression. 68, 69 Curiously the excitatory hormone and neurotransmitter epinephrine significantly increases HDL cholesterol in the bloodstream, 70 while the similar norepinephrine reduces LDL cholesterol. 71 Thus stress has a direct effect on the prevalence of these biomarkers. Of further interest is cholesterol's essential role in the biosynthesis of testosterone, 72 and that HDL cholesterol positively associates with testosterone and yet is reduced by its presence. 73, 74, 75 The importance of the previous sentence is that when testosterone binds to androgen receptors in the brain, it demonstrates protective and reparative effects. 76, 77 Thus a reasonable suggestion can be made that stress plays an important role in stimulating an increase in HDL cholesterol, effectively increasing testosterone production, of which upon binding to androgen receptors protects and or repairs stress related neurological damage. In an animal studies regarding chronic stress, higher levels of the feminine hormone estradiol resulted in augmented physiological stress, while higher levels of the masculine hormone testosterone attenuated physiological stress. 78 These observations may offer an explanation towards the demographics in depression where women are around 33% more likely to suffer from depression in their lifetimes than men. 79 An additional curiosity from animal studies is the related restorative effects of mild exercise upon the neurons of the hippocampus, 80 and may further suggest the biology of the alleviating effects of physical exercise on both anxiety and depression in human studies. 81, 82 
Conclusion
In conclusion, based on pure observation of behavioural symptoms, anxiety and depression are different disorders. Neuroimaging the two disorders reflects the behavioural interpretation through the mostly polarised activity between normal anxiety responses and severe depression. Yet when one proposes the hypothesis that chronic anxiety leads to neural damage, the disorders then lie upon a spectrum of the severity and duration of anxious cognitions and behaviours and the resulting neurological damage, thus appearing to be a single pathology. The biochemical evidence would support this hypothesis of the two behaviours being of the same biological mechanism, clarifying depression as a later consequence of an anxious psychopathology. The author's personal observation is that the psychophysiological stress response to external threats appears to be similar to what the immune response is to internal threats, and that both in excess enact detrimental effects (see Tisconik et al. for an analogous theory in immunology, i.e. the cytokine storm 83 ).
There is also a curious irony of some research declaring neuroticism as the common factor between depression and anxiety, without acknowledging the physiological effects of neurological stress upon anxiety and depression, as the linguistic morphology of "neuroticism" represents a state inclined towards "neurosis", meaning anxiety, tension, and arousal of the nervous system. Linguistically therefore, anxious behaviours are essentially manifestations of neurosis and the two terms can be considered interchangeable, as is indicated by the psychophysiological evidence. Yet it is entirely understandable following the empirical strength of behavioural studies in the earlier half of the previous century and to this day, alongside the lack of present technology in the past, that the behavioural symptoms and thence terminology were the primary means of consolidating the present taxonomy of mental illness. Considering this perspective however, unless a strictly behavioural premise for taxonomy is the focus for diagnosis and treatment, the current ICD-10 and DSM-5 diagnostic criteria may misrepresent the psychopathological nature of mental illness in the case of anxiety and more so depression. From a psychopathological standpoint, a reasonable argument can be made that anxiety and depression are part of the same underlying pathology. This single disorder perspective also offers insight into the widespread success of single process therapies upon numerous and supposedly different disorders. 84 Where considering a possible singular psychopathological model of these disorders would likely be of greatest importance is in refining measures of prevention, intervention, and, when required, recovery oriented medication of mental illness through detailed study and understanding of this underlying anxiety psychopathology.
